Update of COVID-19 and MS – Morbidity and mortality figures

In this webinar, experts share insights on the impact of disease modifying therapies during early phase of the pandemic in the UK and in Italy and go through case histories


  • Prof Richard Nicholas, Consultant Neurologist, Imperial College Healthcare NHS Trust
  • Prof Marco Salvetti, Professor of Neurology, Sapienza University of Rome, Italy
  • Prof Gavin Giovannoni, Professor of Neurology, Barts and The London School of Medicine and Dentistry & Academic Director, MS Academy

To view full video register to OnMedica and then click 'View full content'.